Who should be tested?
HerediGENE is designed for individuals or families, meeting one or more of the following criteria:
- Early age of onset of any type of cancer.
- Individuals with multiple primary tumors.
- Bilateral breast and/or ovarian cancers.
- Same type of cancer occurring in close relatives.
- Cancer incidence in multiple generations of a family.
- Rare tumor occurrence at any age.
Clinical Utility
HerediGENE provides valuable information that can be utilized for reducing the risk of cancer development by assisting the treating physicians to individualize surgical and pharmaceutical management. In addition, it can be used to identify those family members at risk of developing cancer who can benefit from risk reduction management. Furthermore, those family members that do not carry the pathogenic mutation identified in the family can be relieved of the stress of developing hereditary cancer and forego unnecessary interventions.
For more scientific and technical information you can contact us: [email protected]
What you get
Report
An individualized report that summarizes the findings of your genetic profile is provided to you and your physician.
SUPPORT
GeneKor takes care of all the logistics in order for your sample to arrive to our laboratory safely
Interpretation
Our team of experts is here to interpret your results to you and your family.
FAQS
- Are BRCA1/2 genes included?
- What types of cancer does it cover?
- If a pathogenic mutation is found, should family members be tested?
- Why should I choose HerediGENE instead of BRCA1/2?
- If I don’t have family history, should I still choose HerediGENE?
- In how many days will the results be available?
- What type of specimen is required and where is the sample collection made?
- Does the test have any cost coverage from any public/private insurances?
- How can I send my sample and receive my results?
- Why should I sign the consent form?
- Are there any special transportation conditions?